Boston Scientific (BSX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Boston Scientific (BSX) Q2 Earnings and Revenues Surpass Estimates
Boston Scientific (BSX) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.62 per share a year ago.
How To Trade Boston Scientific Stock Ahead Of Its Upcoming Earnings?
Boston Scientific (NYSE:BSX) is set to announce its earnings on Wednesday, July 23, 2025. In the last five years, BSX stock has shown a positive return on the day after earnings announcements in 60% of cases.
Exploring Analyst Estimates for Boston Scientific (BSX) Q2 Earnings, Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings?
BSX eyes strong Q2 with MedSurg momentum, solid Cardiovascular growth and benefits from key tech acquisitions.
Why Boston Scientific (BSX) Outpaced the Stock Market Today
Boston Scientific (BSX) reached $104.33 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close.
Boston Scientific (BSX) Crossed Above the 20-Day Moving Average: What That Means for Investors
Boston Scientific (BSX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, BSX crossed above the 20-day moving average, suggesting a short-term bullish trend.
3 AI-Driven Medical Device Stocks to Watch in 2025
BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Is it Worth Adding Boston Scientific Stock to Your Portfolio Now?
BSX rides on strong MedSurg growth and strategic acquisitions amid currency headwinds.
